Gulf Pharmaceutical Industries PSC (ADX: JULPHAR) is one of the Middle East’s leading pharmaceutical manufacturers, dedicated to producing high-quality medicines across multiple therapeutic areas. With a strong presence in regional and global markets, the company plays a critical role in enhancing healthcare accessibility. By investing in research, innovation, and state-of-the-art manufacturing facilities, Gulf Pharmaceutical Industries ensures the development of cutting-edge pharmaceutical solutions. Its commitment to quality and regulatory excellence positions it as a trusted healthcare provider. As the demand for innovative and affordable healthcare solutions rises, Gulf Pharmaceutical Industries continues to expand its product portfolio, supporting medical advancements and public health initiatives.
Latest shares articles
Market Analysis: EUR/USD nears 1.09 as US NFP undershoots
Softer US labour data and strong Eurozone GDP data reinforce the bullish momentum in EUR/USD
16:03, 7 March 2025
Market volatility lifts on US growth fears heading into February Non-Farm Payrolls data
Market uncertainty grows as US economic data signals a slowdown ahead of February’s Non-Farm Payrolls report.
14:55, 5 March 2025
Wall Street and US Dollar drops as US President Trump pushes ahead with tariffs
US stocks and the dollar decline as President Trump imposes new tariffs on key trading partners. Market uncertainty rises, while European equities gain.
10:29, 4 March 2025
Europe embraces lower CPI as ECB poised for another rate cut
European assets trade higher on Monday as softer CPI reinforces expectations of ECB rate cuts.
17:41, 3 March 2025
Ratings and Reviews
Ratings and Reviews
